Dolby Laboratories, Inc. (DLB)

Dolby Laboratories Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 27, 2024	Sep 27, 2024	Sep 29, 2023	Sep 30, 2022	Sep 24, 2021	Sep 25, 2020
Cash & Equivalents	482.05	482.05	745.36	620.13	1,225	1,072
Short-Term Investments	-	-	139.15	189.21	38.84	46.95
Cash & Short-Term Investments	482.05	482.05	884.51	809.34	1,264	1,119
Cash Growth	-45.50%	-45.50%	9.29%	-35.98%	13.00%	22.09%
Accounts Receivable	512.94	512.94	444.38	419.69	414.93	341.7
Receivables	512.94	512.94	444.38	419.69	414.93	341.7
Inventory	33.73	33.73	35.62	23.55	10.97	25.55
Prepaid Expenses	69.99	69.99	24.44	26.85	29.96	17.88
Restricted Cash	95.71	95.71	72.6	8.24	7.65	8.1
Other Current Assets	-	-	26.26	23.22	32.77	35.14
Total Current Assets	1,194	1,194	1,488	1,311	1,760	1,547
Property, Plant & Equipment	518.16	518.16	521.78	560.01	601.51	618.48
Long-Term Investments	89.27	89.27	97.81	102.51	62.82	52.15
Goodwill	-	-	408.41	365.15	340.69	336.95
Other Intangible Assets	967.72	967.72	167.43	112.27	122.89	152.43
Long-Term Deferred Tax Assets	219.76	219.76	201.86	183.57	156.02	118.88
Other Long-Term Assets	120.61	120.61	94.67	55.15	61.26	91.25
Total Assets	3,110	3,110	2,980	2,690	3,106	2,917
Accounts Payable	17.38	17.38	20.93	14.17	17.78	12.62
Accrued Expenses	347.53	347.53	178.39	143.15	157.69	134.31
Current Portion of Leases	12.24	12.24	13.63	13.26	15.4	15.82
Current Income Taxes Payable	9.05	9.05	4.77	1.27	1.33	3.26
Current Unearned Revenue	31.64	31.64	31.51	18.59	18.47	15.44
Other Current Liabilities	-	-	173.01	87.09	105.03	85.66
Total Current Liabilities	417.84	417.84	422.23	277.52	315.72	267.11
Long-Term Leases	34.75	34.75	37.02	37.69	56.72	65.32
Long-Term Unearned Revenue	34.59	34.59	40	23.2	23.71	24.34
Other Long-Term Liabilities	135.85	135.85	104.04	96	100.43	117.97
Total Liabilities	623.04	623.04	607.58	438.53	501.46	478.92
Common Stock	0.09	0.09	0.09	0.09	0.1	0.1
Retained Earnings	2,496	2,496	2,392	2,298	2,608	2,443
Comprehensive Income & Other	-19.19	-19.19	-36.98	-51.64	-10.03	-10.59
Total Common Equity	2,477	2,477	2,355	2,246	2,598	2,433
Minority Interest	9.73	9.73	17.08	4.84	6.25	5.76
Shareholders' Equity	2,487	2,487	2,372	2,251	2,604	2,438
Total Liabilities & Equity	3,110	3,110	2,980	2,690	3,106	2,917
Total Debt	46.99	46.99	50.65	50.94	72.12	81.14
Net Cash (Debt)	435.06	435.06	833.86	758.4	1,192	1,038
Net Cash Growth	-47.83%	-47.83%	9.95%	-36.38%	14.88%	13.24%
Net Cash Per Share	4.47	4.47	8.53	7.44	11.39	10.08
Filing Date Shares Outstanding	95.39	95.39	95.28	95.96	101.16	100.35
Total Common Shares Outstanding	95.39	95.39	95.76	95.88	101.07	100.3
Working Capital	776.58	776.58	1,066	1,033	1,445	1,280
Book Value Per Share	25.97	25.97	24.59	23.43	25.70	24.25
Tangible Book Value	1,509	1,509	1,779	1,769	2,134	1,943
Tangible Book Value Per Share	15.82	15.82	18.58	18.45	21.12	19.38
Land	-	-	41.9	41.77	42.04	41.96
Buildings	-	-	287.8	287.54	284.15	283.62
Machinery	-	-	418.53	402.9	420.55	389.59
Construction In Progress	-	-	18.33	23.04	22.92	19.55
Leasehold Improvements	-	-	79.99	86.79	88.55	83.76

Source: S&P Capital IQ. Standard template. Financial Sources.